{"id":"ceftriaxone-1gm-for-intravenous-infusion","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Abdominal pain"},{"rate":"1-5%","effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This results in the disruption of the bacterial cell wall, ultimately leading to cell lysis and death. Ceftriaxone is a third-generation cephalosporin antibiotic.","oneSentence":"Ceftriaxone works by inhibiting bacterial cell wall synthesis through inhibition of the enzyme penicillin-binding protein 1B.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:05:14.069Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Skin and skin structure infections"}]},"trialDetails":[{"nctId":"NCT03794765","phase":"PHASE2","title":"Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-04-01","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases, Acute Severe Colitis","enrollment":50},{"nctId":"NCT02177994","phase":"PHASE3","title":"Antibiotic Prophylaxis for Elective Cesarean Section","status":"COMPLETED","sponsor":"Ain Shams Maternity Hospital","startDate":"2013-09","conditions":"Infection of Cesarian Section Wound Following Delivery","enrollment":328}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["cefaxon"],"phase":"phase_3","status":"active","brandName":"ceftriaxone 1gm for intravenous infusion","genericName":"ceftriaxone 1gm for intravenous infusion","companyName":"Ain Shams Maternity Hospital","companyId":"ain-shams-maternity-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ceftriaxone works by inhibiting bacterial cell wall synthesis through inhibition of the enzyme penicillin-binding protein 1B. Used for Community-acquired pneumonia, Skin and skin structure infections.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}